You just read:

Heart Metabolics and FDA Reach Agreement on Special Protocol Assessment for Single Phase 3 Trial of Perhexiline in Hypertrophic Cardiomyopathy

News provided by

Heart Metabolics Limited

15 Apr, 2015, 13:00 BST